News

British Menopause Society further update on HRT supply shortages (28 September 2020)

The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners in response to the ongoing HRT shortages. The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and [...]

2020-09-28T12:37:02+01:0028 September 2020|

HRT and breast cancer statement in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020

This is an updated Joint BMS, IMS, EMAS, RCOG and AMS Position Statement on HRT and breast cancer risk and includes a summary of the evidence on dydrogesterone. We are aware that the statement is likely to be used by healthcare professionals to guide clinical practice and we believe this additional information would be of [...]

2020-09-14T12:15:48+01:0014 September 2020|

BMS, IMS, EMAS, RCOG and AMS Joint Statement

A joint statement has been issued by the British Menopause Society, the International Menopause Society, the European Menopause and Andropause Society, the Royal College of Obstetricians and Gynaecologists and the Australasian Menopause Society on menopausal hormone therapy (MHT) and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020.

2020-08-18T09:37:16+01:0018 August 2020|

BMS, RCOG, RCGP, FSRH, FOM and FPH Position Statement

A joint statement has been issued by the British Menopause Society, the Royal College of Obstetricians and Gynaecologists, the Royal College of General Practitioners, the Faculty of Sexual and Reproductive Healthcare, the Faculty of Occupational Medicine and the Faculty of Public Health in response to the BMA report ‘Challenging the culture on menopause for doctors’.

2020-08-14T18:08:24+01:0014 August 2020|

New non-hormonal treatment for hot flushes

Menopausal hot flushes and sweats affect around 80% of women, can cause significant distress and can last for many years. Hormone Replacement Therapy is recommended as first line treatment, but is not appropriate nor desired by all women with symptoms. This is especially relevant to women who have had hormone dependant cancer. Non hormonal treatments [...]

2020-07-09T12:09:52+01:009 July 2020|

Possible link between hormones and Alzheimer’s Dementia

It has been recognised for many years that more women than men are affected by Alzheimer’s Dementia (AD). Female hormones have been thought to play a role and new information adds more evidence to the debate. A recently published study investigated the differences in brain biomarkers of AD in men and women. (A biomarker is [...]

2020-07-13T10:16:44+01:009 July 2020|